Cargando…
Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis
The human prolyl isomerase PIN1, best known for its association with carcinogenesis, has recently been indicated in the disease of pancreatic ductal adenocarcinoma (PDAC). However, the functions of PIN1 and the feasibility of targeting PIN1 in PDAC remain elusive. For this purpose, we examined the e...
Autores principales: | Chen, Linying, Xu, Xiao, Wen, Xinxin, Xu, Shenmin, Wang, Long, Lu, Wenxian, Jiang, Mingting, Huang, Jing, Yang, Dayun, Wang, Jichuang, Zheng, Min, Zhou, Xiao Zhen, Lu, Kun Ping, Liu, Hekun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676117/ https://www.ncbi.nlm.nih.gov/pubmed/31148345 http://dx.doi.org/10.1111/cas.14085 |
Ejemplares similares
-
Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways
por: Liao, Xin-Hua, et al.
Publicado: (2017) -
Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma
por: Zheng, Min, et al.
Publicado: (2017) -
MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways
por: Yan, Xingxue, et al.
Publicado: (2017) -
Correction to: Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways
por: Lian, Xiaolan, et al.
Publicado: (2018) -
Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways
por: Lian, Xiaolan, et al.
Publicado: (2018)